Press release
Actinic Keratosis Treatment Market 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Medication, Therapies, and Companies by DelveInsight
Actinic Keratosis Treatment Market
(Albany, USA) DelveInsight's "Actinic Keratosis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Actinic Keratosis, historical and forecasted epidemiology as well as the Actinic Keratosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Actinic Keratosis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Actinic Keratosis market size from 2020 to 2034, segmented by seven major markets. The Report also covers current Actinic Keratosis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Actinic Keratosis market.
Request for a Free Sample Report @ Actinic Keratosis Market Forecast [https://www.delveinsight.com/report-store/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Some facts of the Actinic Keratosis Market Report are:
* According to DelveInsight, Actinic Keratosis market size is expected to grow at a decent CAGR by 2034.
* Leading Actinic Keratosis companies working in the market are VidacPharma, DFB Soria, G&E Herbal Biotechnology, Promius Pharma, Sol-Gel Technologies, PROVECTUS BIOPHARMACEUTICALS, Coegin Pharma, Jupiter Wellness, MedC Biopharma CorporationGlaukos Corporation, Ivantis Inc., Allergan, Ellex, Alcon, BVI, Johnson and Johnson Services, Inc., Microsurgical technology, Molteno Ophthalmic Ltd. ,New World Medical , Santen Pharmaceutical, Sight Scientific, Topcon Corporation, Merck & Co., Inc., Carl Zeiss AG, Alimera Sciences, Annexin Pharmaceuticals, Amgen Inc., Cangene Corporation, BD and Bosch Healthcare Solutions GmbH among others.
* Key Actinic Keratosis Therapies expected to launch in the market are AVX001, VDA-1102, and others.
* In November 2024, Vidac Pharma has secured 600,000 ($645,651) in additional funding to advance the clinical development of its two lead cancer candidates. Announced during the company's recent shareholder meeting, this funding from existing investors will allow Vidac to initiate a new Phase IIb trial for its lead candidate, VDA-1102 (tuvatexib) ointment. The hexokinase 2 inhibitor is being studied for its potential in treating advanced cases of actinic keratosis, a skin condition that may progress to cutaneous squamous cell carcinoma (SCC).
* Additionally, the launch of new therapies such as VDA-1102, SR-T100 Gel, and other innovative topical treatments is anticipated to enhance treatment outcomes and broaden market prospects.
* According to Chetty P et al., the prevalence of AK varies from 6-60%, depending on age, phototype and other predisposing risk factors (most notably immunosuppressed status, outdoor workers), and is increasing
* In a study conducted by Schaefer et al., it was found that the standardized prevalence of AK from dermatological examinations was 2.7%; the rate increased with age (11.5% in the group 60-70 years) and was higher for men (3.9%) than for women (1.5%)
Actinic Keratosis Overview
Actinic keratosis (AK) is a common skin condition characterized by rough, scaly patches that develop due to long-term exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Actinic keratosis usually occurs on areas of the body that receive the most sun exposure, such as the face, scalp, ears, neck, and hands.
These lesions are usually small, red, or flesh-colored, with a rough texture resembling sandpaper. While actinic keratosis is not cancerous in itself, it is considered a precancerous condition, as a small percentage of Actinic keratosis may progress to squamous cell carcinoma, a type of skin cancer.
It is important to have Actinic keratosis evaluated and treated by a healthcare professional. Treatment options include topical creams, cryotherapy (freezing), chemical peels, photodynamic therapy, or surgical removal. Prevention is crucial, and measures such as sun protection (using sunscreen, wearing protective clothing, and seeking shade), regular skin examinations, and avoiding artificial UV radiation can help reduce the risk of developing actinic keratosis. Early detection and treatment of Actinic keratosis can significantly lower the risk of skin cancer.
Learn more about Actinic Keratosis treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ [https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Actinic Keratosis Market
The Actinic Keratosis market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Actinic Keratosis market trends by analyzing the impact of current Actinic Keratosis therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.
This segment gives a thorough detail of the Actinic Keratosis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Actinic Keratosis market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Actinic Keratosis market in 7MM is expected to witness a major change in the study period 2020-2034.
Actinic Keratosis Epidemiology
The Actinic Keratosis epidemiology section provides insights into the historical and current Actinic Keratosis patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Actinic Keratosis market report also provides the diagnosed patient pool, trends, and assumptions.
Explore more about Actinic Keratosis Epidemiology @ [https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Actinic Keratosis Drugs Uptake
This section focuses on the uptake rate of the potential Actinic Keratosis drugs recently launched in the Actinic Keratosis market or expected to be launched in 2020-2034. The analysis covers the Actinic Keratosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Actinic Keratosis Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Actinic Keratosis market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Actinic Keratosis Pipeline Development Activities
The Actinic Keratosis report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Actinic Keratosis key players involved in developing targeted therapeutics.
Learn more about the emerging Actinic Keratosis Market drivers and barriers @ [https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Actinic Keratosis Therapeutics Assessment
Major key companies are working proactively in the Actinic Keratosis Therapeutics market to develop novel therapies which will drive the Actinic Keratosis treatment markets in the upcoming years are VidacPharma, DFB Soria, G&E Herbal Biotechnology, Promius Pharma, Sol-Gel Technologies, PROVECTUS BIOPHARMACEUTICALS, Coegin Pharma, Jupiter Wellness, MedC Biopharma CorporationGlaukos Corporation, Ivantis Inc., Allergan, Ellex, Alcon, BVI, Johnson and Johnson Services, Inc., Microsurgical technology, Molteno Ophthalmic Ltd. ,New World Medical , Santen Pharmaceutical, Sight Scientific, Topcon Corporation, Merck & Co., Inc., Carl Zeiss AG, Alimera Sciences, Annexin Pharmaceuticals, Amgen Inc., Cangene Corporation, BD and Bosch Healthcare Solutions GmbH among others.
Learn more about the emerging Actinic Keratosis therapies & key companies @ Actinic Keratosis Therapies and Companies [https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Actinic Keratosis Report Key Insights
1. Actinic Keratosis Patient Population
2. Actinic Keratosis Market Size and Trends
3. Key Cross Competition in the Actinic Keratosis Market
4. Actinic Keratosis Market Dynamics (Key Drivers and Barriers)
5. Actinic Keratosis Market Opportunities
6. Actinic Keratosis Therapeutic Approaches
7. Actinic Keratosis Pipeline Analysis
8. Actinic Keratosis Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Actinic Keratosis Market
Table of Contents
1. Key Insights
2. Executive Summary
3. Actinic Keratosis Competitive Intelligence Analysis
4. Actinic Keratosis Market Overview at a Glance
5. Actinic Keratosis Disease Background and Overview
6. Actinic Keratosis Patient Journey
7. Actinic Keratosis Epidemiology and Patient Population
8. Actinic Keratosis Treatment Algorithm, Current Treatment, and Medical Practices
9. Actinic Keratosis Unmet Needs
10. Key Endpoints of Actinic Keratosis Treatment
11. Actinic Keratosis Marketed Products
12. Actinic Keratosis Emerging Therapies
13. Actinic Keratosis Seven Major Market Analysis
14. Attribute Analysis
15. Actinic Keratosis Market Outlook (7 major markets)
16. Actinic Keratosis Access and Reimbursement Overview
17. KOL Views on the Actinic Keratosis Market
18. Actinic Keratosis Market Drivers
19. Actinic Keratosis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=actinic-keratosis-treatment-market-2034-ema-pdma-fda-approvals-prevalence-clinical-trials-medication-therapies-and-companies-by-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Actinic Keratosis Treatment Market 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Medication, Therapies, and Companies by DelveInsight here
News-ID: 3813146 • Views: …
More Releases from ABNewswire
Avanti Rides Debuts in Southern Florida, Transforming How Drivers and Passengers …
Miami, FL - Avanti Rides introduces a new chapter in ride-hailing by combining passenger safety, driver empowerment, and seamless technology into a single app. Designed for the evolving needs of both drivers and riders, Avanti is delivering smarter bookings, stronger protection, and unmatched flexibility.
Built for Drivers Who Want More Than Just Rides
Avanti Rides recognizes that drivers are the foundation of the platform and offers a range of benefits focused on…
UVS-IT Unveils Guide to Choosing the Best Managed IT Services in Atlanta
Hey there, Atlanta business warriors! Have you ever felt that picking the perfect Managed IT Service is a bit like choosing the ultimate wingman for your company's tech needs? Trust me, it's not just a matter of finding someone who looks good on paper. With technology increasingly steering the ship of our businesses, selecting a reliable Managed IT Service is becoming as crucial as that morning cup of coffee we…
3D-Engineering: How 3D Scanning Services Are Revolutionizing Modern Engineering …
Imagine being able to capture every nook and cranny of an object down to the most intricate detail. Sounds magical, right? That's the power of 3D scanning services [https://3d-engineering.net/engineering-services/3d-laser-scanning-services/] in today's engineering projects. Across industries, from automotive and construction to aerospace and healthcare, 3D scanning is transforming how things are measured, mapped, and made. Whether you're designing a new building or manufacturing precision components, 3D scanning takes you from the…
SLCLawyer: How a Separation Agreement Can Help Couples Save Thousands in Legal F …
Image: https://www.abnewswire.com/upload/2025/10/7d762be2535d9a3c2274975ea0a87869.jpg
When John and Mary decided to separate after 12 years of marriage, they thought they could handle it on their own. Money was tight, emotions were high, and the internet offered dozens of free and cheap separation agreement templates. They downloaded one, filled in the blanks, and signed it at the kitchen table.
At first, it seemed like a practical solution. They avoided paying lawyers, saved a few hundred dollars,…
More Releases for Actinic
Actinic Keratosis Market Emerging Trends and Growth Prospects 2034
Introduction
Actinic keratosis (AK), also known as solar keratosis, is one of the most common precancerous skin conditions caused by long-term ultraviolet (UV) radiation exposure. It primarily affects older adults with fair skin and is considered a precursor to squamous cell carcinoma, making early detection and treatment critical. With rising awareness of skin cancer prevention, growing dermatology consultations, and expanding therapeutic innovations, the global actinic keratosis market is experiencing significant growth.
Over…
Global Actinic Keratosis Market Report Forecast to 2027
A rough, scaly area on the skin called an actinic keratosis Market develops after years of sun exposure. It commonly appears on the cheeks, lips, ears, forearms, scalp, neck, and backs of the hands. An actinic keratosis, also known as a sun keratosis, develops slowly and generally appears in persons over the age of 40. By limiting your sun exposure and protecting your skin from ultraviolet (UV) radiation, you…
Actinic Keratosis Market Insight, Epidemiology and Market Forecast -2026
The report studies the global Actinic Keratosis Market with many aspects of the industry like the market size, market status, market trends, and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. The report offers valuable insight into the Actinic Keratosis Market progress and approaches related to the market with an analysis of each region. The report goes on to…
Actinic Keratosis Treatment Market To Increase at Steady Growth Rate
Actinic keratosis (AK) is a form of skin cancer and it is also known as solar keratosis. This indication tends to affect the sun-exposed parts of the skin such as face, bald scalp, lips, and the back of the hands among others. As a result of the exposure, the skin tends to become rough, uneven and display a warty look. Approximately, 10% of the exposed areas tend to develop squamous…
United States Actinic Keratosis Treatment Market Report 2016
MarketResearchReports.biz has recently announced the addition of a market study “ United States Actinic Keratosis Treatment Market Report 2016 ”, is a comparative analysis of the global market.
Notes:
Sales, means the sales volume of Actinic Keratosis Treatment
Revenue, means the sales value of Actinic Keratosis Treatment
This report studies sales (consumption) of Actinic Keratosis Treatment in United States market, focuses on the top players, with sales, price, revenue and market…
Actinic Launches Ecommerce Fraud Checking Service with The 3rd Man
West Byfleet, Surrey – 3 June 2009 – With research showing consumers increasingly worried about card security when shopping online, Actinic (www.actinic.co.uk), the UK expert in ecommerce for small and medium businesses, has responded to the challenge with a major enhancement to its Actinic Payments service for combating card-not-present (CNP) fraud. Actinic Payments’ merchants now have seamless access to the anti-fraud, card verification service from The 3rd Man for no…
